Pharmatrans hosts webinar on new DiCOM SANAQ® direct compression platform

Allschwil, Switzerland: – Pharmatrans Sanaq (Pharmatrans) will host an online webinar to discuss higher quality direct compression (DC) formulation applications for its recently introduced range of DiCOM SANAQ® high functionality co-processed excipients.

The one hour webinar: ‘DiCOM SANAQ: A move forward into direct compression’ will take place on November 10, 2020, starting at 1400hrs CET (UTC +1:00). Registration is free of charge (see Resources).

Direct Compression advantages

The Zoom-based live webcast will be presented by Dr. Marco Resciniti, Technical Marketing Manager for Pharmatrans Sanaq AG, who will show how this innovative DC platform uses customized excipients to provide materials tailored to be used for DC indicated even in continuous manufacturing (CM).

Dr. Resciniti, a pharmacist with PhD in Pharma Technology, will explain how DiCOM SANAQ offers ready-made blends suitable for oral solid dosage forms to assist the customer achieve the ideal formulation, simplifying and accelerating the product manufacturing process by providing excipient mixtures with excellent and superior compressibility parameters compared with single and pure excipients.

CM benefits

He will also cover CM processes that use of DICOM SANAQ to enhance product performance and reduce formulation variability, while monitoring product quality in real time, using PAT tools, to reduce cost and delay.

The use of binary or multiple mixtures of co processed excipients offers the option to use materials requiring fewer feeders in CM and with better suitability for DC than single excipients.

About Pharmatrans Sanaq

Founded in in 1982 and headquartered at Allschwil, near Basel, Switzerland,  Pharmatrans Sanaq AG is a pharmaceutical distributor that specializes in marketing and promotion of excipients and Innovative ingredients. It also provides its own formulation expertise to give customers a complete portfolio of technical and smart solutions for the formulation development and manufacture of solid and semisolid dosage forms.

Pharmatrans Sanaq offers innovative solutions based on a safe analytical and quality (SANAQ) approach, leveraging solid experience, industrial know-how, regulatory skills, strategic partnerships with R&D centers, collaboration with international universities and in-house expertise from its team of formulator scientists to deliver support in the excipients field from basic materials to ready-made products for customized solutions.

Pharmatrans Sanaq offers a wide range of specialized pharmaceutical excipients and active ingredients (APIs) that include microcrystalline cellulose (MCC), tartaric acid pellets (TAP), sugar spheres, Mannitol pellets, calcium carbonate pellets, silicon dioxide pellets and co-processed excipients.

Pharmatrans also develops specific tailored products based on specific customer requirements, process technology and applications. To do this, Pharmatrans works in close partnerships with an international network of  advanced, selected and qualified CMO and CDMO developers and manufacturers, several of whom hold  significant  international and local process patents.

Further information at: www.pharmatrans-sanaq.com

Resources 

Click on Pharmatrans Webinar to register for the event.